AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
(From Asia Pulse)
(Full text of a statement. Contact details below.)
SEOUL, Republic of Korea & BILLERICA, Mass.--(BUSINESS WIRE)--Aug. 10, 2005--Bruker Daltonics Inc. today announces that it has obtained registration of its leading autoflex(R) II MALDI-TOF mass spectrometers as Class I Medical Devices with the Korea Food and Drug Administration.
MALDI-TOF mass spectrometry is increasingly being applied to the areas of clinical proteomics, functional genomics and biomarker discovery as a clinical research tool. With recent advances, usage of MALDI-TOF in in-vitro diagnostics (IVD) applications has become very promising. Bruker Daltonics has now taken the important step of registering …